Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D004247:DNA / Q000096:biosynthesis; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood / Q000276:immunology; D006689:Hodgkin Disease / Q000097:blood / Q000276:immunology; D006801:Humans; D007223:Infant; D037102:Lectins; D007945:Leukemia, Lymphoid / Q000097:blood / Q000276:immunology; D008175:Lung Neoplasms / Q000097:blood / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology* / Q000378:metabolism; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000276:immunology; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood*; D012313:RNA / Q000096:biosynthesis; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D037102:Lectins; D014316:Tritium; D012313:RNA; D004247:DNA; D013936:Thymidine; D014529:Uridine